3
Announcements
Trials
Browse
Landscape
Status
Unknown
3
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Pilonidal Sinus
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Choledochal Cyst
1
Interventions
Fluorouracil
255
Leucovorin
224
Oxaliplatin
218
Irinotecan
206
Bevacizumab
199
Capecitabine
144
Cetuximab
136
Panitumumab
68
Folfox protocol
63
regorafenib
50
Colonoscopy
44
pembrolizumab
42
IFL protocol
39
Radiotherapy
32
Nivolumab
31
Drug Therapy
27
trifluridine tipiracil drug combination
26
Gemcitabine
24
Blood Specimen Collection
23
Chemotherapy, Adjuvant
20
Surveys and Questionnaires
19
Celecoxib
18
Surgical Procedures, Operative
16
durvalumab
15
Neoadjuvant Therapy
15
Cyclophosphamide
14
Cisplatin
14
aflibercept
13
Standard of Care
13
Pemetrexed
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colorectal Neoplasms
×
Conversion to Open Surgery
×
Clear all
NCT03683446
2018-09-25
NSQIPc
The Methodist Hospital Research Institute
Completed
31,795 enrolled